NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the relaunch of TRIESENCE ® (triamcinolone acetonide injectable suspension) ...
Please provide your email address to receive an email when new articles are posted on . HUENENBERG, Switzerland — The U.S. Food and Drug Administration has approved Alcon's Triesence injectable 40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback